Effexor and Concomitant disease progression - a phase IV clinical study of FDA data

Summary:

Concomitant disease progression is reported as a side effect among people who take Effexor (venlafaxine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Klonopin, and have Coronary heart disease.

The phase IV clinical study analyzes which people have Concomitant disease progression when taking Effexor. It is created by eHealthMe based on reports of 92,291 people who have side effects when taking Effexor from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Concomitant disease progression?

Concomitant disease progression (progress in accompanying disease) is found to be associated with 372 drugs and 622 conditions by eHealthMe. Check the latest studies of Concomitant disease progression.

On Jul, 10, 2026

92,291 people reported to have side effects when taking Effexor.
Among them, 13 people (0.01%) have Concomitant disease progression.

Could Effexor cause Concomitant disease progression?

Among these 13 people:

How long have people been on Effexor when they have Concomitant disease progression? *

What is the gender of people who have Concomitant disease progression when taking Effexor? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Concomitant disease progression when taking Effexor? *

What are other drugs people take besides Effexor? *

What are other side effects people have besides Concomitant disease progression? *

Overdose: 5 people, 38.46%
Suicide Attempt: 5 people, 38.46%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 23.08%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 3 people, 23.08%
Suicidal Ideation: 3 people, 23.08%
Parkinson's Disease: 3 people, 23.08%
Joint Pain: 2 people, 15.38%
Swallowing Difficulty: 2 people, 15.38%
Confusional State: 2 people, 15.38%
White Blood Cell Count Increased: 1 person, 7.69%

What are the existing conditions these people have? *

Insomnia (sleeplessness): 3 people, 23.08%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 23.08%
High Blood Pressure: 2 people, 15.38%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 7.69%
Bipolar Disorder (mood disorder): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and have Concomitant disease progression?

- Check whether Concomitant disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effexor:

Effexor (99,493 reports)

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Concomitant disease progression:

Concomitant disease progression (372 drugs)

Browse all the conditions that are associated with Concomitant disease progression:

Concomitant disease progression (622 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.